All companies
Enovis Corporation logo

What smart money is saying about Enovis CorporationUnited States flag

ENOV · Industrials · Industrial - Machinery · Market cap $1.52B

1 fund in our archive has pitched Enovis Corporation — most recently Royce in March 2025.

Company profile

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Get an email when a fund writes about it

Fund coverage · 1 thesis

  • Royce
    March 2025

    Enovis Corporation is an orthopedic-focused medical technology company poised for high-single-digit organic growth and EBITDA margin expansion after overcoming integration challenges from its 2024 acquisition of Lima.

    Read the full thesis

Read every full thesis on Enovis Corporation

Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans